Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions

• Barry D. Greenberg,
• Cynthia A. Lemere,
• Lisa L. Barnes,
• Kathleen M. Hayden,
• Walter A. Kukull,
• Esther S. Oh,
• Peter J. Snyder,
• Mark Supiano,
• Peggye Dilworth‐Anderson

Affiliations

Barry D. Greenberg

Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USA

Cynthia A. Lemere

Ann Romney Center for Neurologic Diseases Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

Lisa L. Barnes

Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois USA

Kathleen M. Hayden

Wake Forest University School of Medicine Winston‐Salem North Carolina USA

Walter A. Kukull

Department of Epidemiology University of Washington Seattle Washington USA

Esther S. Oh

Departments of Medicine Psychiatry and Behavioral Sciences and Pathology Johns Hopkins University School of Medicine Baltimore Maryland USA

Peter J. Snyder

Department of Biomedical & Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island Department of Neurology Alpert Medical School of Brown University Providence Rhode Island USA

Mark Supiano

Division of Geriatrics, University of Utah Spencer Eccles Fox School of Medicine University of Utah School on Aging Salt Lake City Utah USA

Peggye Dilworth‐Anderson

Gillings School of Global Public Health University of North Carolina‐Chapel Hill Chapel Hill North Carolina USA